The ADAM17 sheddase complex regulator iTAP/Frmd8 modulates inflammation and tumor growth

Marina Badenes1,2,3, Emma Burbridge1,4, Ioanna Oikonomidi1

  • 1Instituto Gulbenkian de Ciência, Oeiras, Portugal.

Life Science Alliance
|January 31, 2023
PubMed

Insights

The FERM domain-containing protein iTAP/Frmd8 protects the metalloprotease ADAM17 from degradation. Loss of iTAP/Frmd8 impairs inflammatory repair and cancer growth, offering a targeted therapeutic approach for ADAM17-related diseases.

Area of Science:

  • Molecular and Cellular Biology
  • Biochemistry
  • Immunology

Background:

  • ADAM17 is a metalloprotease crucial for shedding TNF and EGF ligands, operating within a complex with iRhoms.
  • iTAP/Frmd8, an iRhom-binding protein, stabilizes ADAM17 and iRhom2 by preventing lysosomal degradation.

Purpose of the Study:

  • To investigate the pathophysiological roles of iTAP/Frmd8 by analyzing its impact on ADAM17-associated phenotypes in mice.
  • To explore the potential of iTAP/Frmd8 as a therapeutic target for inflammatory diseases and cancer.

Main Methods:

  • Generation and characterization of iTAP/Frmd8 knockout (KO) mice.
  • Assessment of inflammatory and intestinal epithelial barrier repair functions in iTAP/Frmd8 KO mice.
  • Evaluation of iTAP/Frmd8's role in cancer cell growth and the tumor microenvironment.

Main Results:

  • iTAP/Frmd8 KO mice displayed defects in inflammatory and intestinal epithelial barrier repair, distinct from global ADAM17 loss phenotypes.
  • iTAP/Frmd8 was found to regulate cancer cell proliferation both intrinsically and by influencing the tumor microenvironment.
  • Loss of iTAP/Frmd8 did not replicate the collateral defects observed with global ADAM17 deficiency.

Conclusions:

  • iTAP/Frmd8 plays a critical role in regulating ADAM17-mediated processes, particularly in inflammatory responses and epithelial repair.
  • Targeting iTAP/Frmd8 offers a promising strategy for modulating ADAM17 activity in specific contexts like chronic inflammation and cancer.
  • Pharmacological targeting of iTAP/Frmd8 could provide therapeutic benefits while mitigating the systemic side effects associated with broad ADAM17 inhibition.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K